Artificial Pancreas Device Systems Market By Type (Threshold Suspend Device Systems, Hybrid Closed-Loop Systems, Control-to-Range (CTR) Systems, Control-to-Target (CTT) Systems, Fully Closed-Loop Systems), By Component (Continuous Glucose Monitor {Sensors, Transmitters, Receivers}, Insulin Pump {Tubed Pumps, Tubeless Pumps}, Others); By Technology (Single-Hormone Systems, Dual-Hormone Systems, Others), By Insulin Delivery Method (Subcutaneous Insulin Delivery, Intraperitoneal Insulin Delivery), By Distribution Channel (Online Retail, Hospitals, and Specialty Pharmacies, Retail Pharmacies), By End-User (Hospitals and Clinics, Home Care Settings, Specialized Diabetes Clinics, Others), Global Market Size, Segmental analysis, Regional Overview, Company share analysis, Leading Company Profiles And Market Forecast, 2025 – 2035

Table of Contents

1. Methodology & Report Coverage

1.1. Definition & Objective

1.2. Market Evaluation & forecast parameter

1.3. Research Methodology

1.4. Data Validation Sources

1.4.1. Secondary Research

1.4.2. Primary Research

2. Market Overview

3. Artificial Pancreas Device Systems Market: Market Dynamics

3.1. Executive Summary

3.2. Market Driving Factors

3.2.1. Technological advancements in glucose monitoring and insulin delivery systems.

3.2.2. Integration of AI and machine learning optimizes device efficiency and personalization.

3.2.3. Rising prevalence of diabetes worldwide boosts demand for advanced management solutions.

3.3. Key industry pitfalls & challenges

3.3.1. Technical complexities in device design and calibration hinder adoption rates.

3.3.2. Concerns regarding device accuracy and reliability affect consumer confidence.

3.3.3. High costs of artificial pancreas devices limit accessibility for patients.

3.4. Market Opportunities

3.4.1. Customization for pediatric and geriatric users broadens target market segments

3.4.2. Growing investment in R&D fosters innovation in dual-hormone delivery systems.

3.4.3. The development of compact, user-friendly devices enhances patient compliance and usage.

3.5. Porter’s Five Forces Analysis

3.6. PESTLE Analysis

3.7. Regulatory landscape

3.8. Investment Landscape

3.9. ESG Scenario

3.10. Competitive landscape

3.10.1. Company Market Share

3.10.2. Market Positioning

3.10.3. Strategy framework

3.10.4. Recent Acquisitions & Mergers

4. Artificial Pancreas Device Systems Market, Type Segment Analysis

4.1. Overview Dynamics

4.1.1. Market Revenue Share, By Type, 2025 & 2035

4.1.2. Key Market Trends, Growth Factors, & Opportunities

4.2. Threshold Suspend Device Systems

4.2.1. Market Size and Forecast, 2025-2035 (USD Million)

4.3. Hybrid Closed-Loop Systems

4.3.1. Market Size and Forecast, 2025-2035 (USD Million)

4.4. Control-to-Range (CTR) Systems

4.4.1. Market Size and Forecast, 2025-2035 (USD Million)

4.5. Control-to-Target (CTT) Systems

4.5.1. Market Size and Forecast, 2025-2035 (USD Million)

4.6. Fully Closed-Loop Systems

4.6.1. Market Size and Forecast, 2025-2035 (USD Million)

5. Artificial Pancreas Device Systems Market, Component Segment Analysis

5.1. Overview

5.1.1. Market Revenue Share, By Component, 2025 & 2035

5.1.2. Key Market Trends, Growth Factors, & Opportunities

5.2. Continuous Glucose Monitor (CGM)

5.2.1. Market Size and Forecast, 2025-2035 (USD Million)

5.2.2. Sensors

5.2.2.1. Market Size and Forecast, 2025-2035 (USD Million)

5.2.3. Transmitters

5.2.3.1. Market Size and Forecast, 2025-2035 (USD Million)

5.2.4. Receivers

5.2.4.1. Market Size and Forecast, 2025-2035 (USD Million)

5.3. Insulin Pump

5.3.1. Market Size and Forecast, 2025-2035 (USD Million)

5.3.2. Tubed Pumps

5.3.2.1. Market Size and Forecast, 2025-2035 (USD Million)

5.3.3. Tubeless Pumps

5.3.3.1. Market Size and Forecast, 2025-2035 (USD Million)

5.4. Others

5.4.1. Market Size and Forecast, 2025-2035 (USD Million)

6. Artificial Pancreas Device Systems Market, Technology Segment Analysis

6.1. Overview

6.1.1. Market Revenue Share, By Technology, 2025 & 2035

6.1.2. Key Market Trends, Growth Factors, & Opportunities

6.2. Single-Hormone Systems

6.2.1. Market Size and Forecast, 2025-2035 (USD Million)

6.3. Dual-Hormone Systems

6.3.1. Market Size and Forecast, 2025-2035 (USD Million)

6.4. Others

6.4.1. Market Size and Forecast, 2025-2035 (USD Million)

7. Artificial Pancreas Device Systems Market, Insulin Delivery Method Segment Analysis

7.1. Overview

7.1.1. Market Revenue Share, By Insulin Delivery Method, 2025 & 2035

7.1.2. Key Market Trends, Growth Factors, & Opportunities

7.2. Subcutaneous Insulin Delivery

7.2.1. Market Size and Forecast, 2025-2035 (USD Million)

7.3. Intraperitoneal Insulin Delivery

7.3.1. Market Size and Forecast, 2025-2035 (USD Million)

8. Artificial Pancreas Device Systems Market, Distribution Channel Segment Analysis

8.1. Overview

8.1.1. Market Revenue Share, By Distribution Channel, 2025 & 2035

8.1.2. Key Market Trends, Growth Factors, & Opportunities

8.2. Online

8.2.1. Market Size and Forecast, 2025-2035 (USD Million)

8.3. Hospitals and Specialty Pharmacies

8.3.1. Market Size and Forecast, 2025-2035 (USD Million)

8.4. Retail Pharmacies

8.4.1. Market Size and Forecast, 2025-2035 (USD Million)

9. Artificial Pancreas Device Systems Market, End-user Segment Analysis

9.1. Overview

9.1.1. Market Revenue Share, By End-user, 2025 & 2035

9.1.2. Key Market Trends, Growth Factors, & Opportunities

9.2. Hospitals and Clinics

9.2.1. Market Size and Forecast, 2025-2035 (USD Million)

9.3. Home Care Settings

9.3.1. Market Size and Forecast, 2025-2035 (USD Million)

9.4. Specialized Diabetes Clinics

9.4.1. Market Size and Forecast, 2025-2035 (USD Million)

9.5. Others

9.5.1. Market Size and Forecast, 2025-2035 (USD Million)

10. Artificial Pancreas Device Systems Market, Region Segment Analysis

10.1. Overview

10.1.1. Global Market Revenue Share, By Region, 2025 & 2035

10.1.2. Global Market Revenue, By Region, 2025-2035 (USD Million)

10.2. North America

10.2.1. North America Market Revenue, By Country, 2025-2035 (USD Million)

10.2.2. North America Market Revenue, By Type, 2025-2035

10.2.3. North America Market Revenue, By Component, 2025-2035

10.2.4. North America Market Revenue, By Technology, 2025-2035

10.2.5. North America Market Revenue, By Insulin Delivery Method, 2025-2035

10.2.6. North America Market Revenue, By Distribution Channel, 2025-2035

10.2.7. North America Market Revenue, By End-user, 2025-2035

10.2.8. The U.S.

10.2.8.1. U.S. Market Revenue, By Type, 2025-2035

10.2.8.2. U.S. Market Revenue, By Component, 2025-2035

10.2.8.3. U.S. Market Revenue, By Technology, 2025-2035

10.2.8.4. U.S. Market Revenue, By Insulin Delivery Method, 2025-2035

10.2.8.5. U.S. Market Revenue, By Distribution Channel, 2025-2035

10.2.8.6. U.S. Market Revenue, By End-user, 2025-2035

10.2.9. Canada

10.2.9.1. Canada Market Revenue, By Type, 2025-2035

10.2.9.2. Canada Market Revenue, By Component, 2025-2035

10.2.9.3. Canada Market Revenue, By Technology, 2025-2035

10.2.9.4. Canada Market Revenue, By Insulin Delivery Method, 2025-2035

10.2.9.5. Canada Market Revenue, By Distribution Channel, 2025-2035

10.2.9.6. Canada Market Revenue, By End-user, 2025-2035

10.3. Europe

10.3.1. Europe Market Revenue, By Country, 2025-2035(USD Million)

10.3.2. Europe Market Revenue, By Type, 2025-2035

10.3.3. Europe Market Revenue, By Component, 2025-2035

10.3.4. Europe Market Revenue, By Technology, 2025-2035

10.3.5. Europe Market Revenue, By Insulin Delivery Method, 2025-2035

10.3.6. Europe Market Revenue, By Distribution Channel, 2025-2035

10.3.7. Europe Market Revenue, By End-user, 2025-2035

10.3.8. Germany

10.3.8.1. Germany Market Revenue, By Type, 2025-2035

10.3.8.2. Germany Market Revenue, By Component, 2025-2035

10.3.8.3. Germany Market Revenue, By Technology, 2025-2035

10.3.8.4. Germany Market Revenue, By Insulin Delivery Method, 2025-2035

10.3.8.5. Germany Market Revenue, By Distribution Channel, 2025-2035

10.3.8.6. Germany Market Revenue, By End-user, 2025-2035

10.3.9. France

10.3.9.1. France Market Revenue, By Type, 2025-2035

10.3.9.2. France Market Revenue, By Component, 2025-2035

10.3.9.3. France Market Revenue, By Technology, 2025-2035

10.3.9.4. France Market Revenue, By Insulin Delivery Method, 2025-2035

10.3.9.5. France Market Revenue, By Distribution Channel, 2025-2035

10.3.9.6. France Market Revenue, By End-user, 2025-2035

10.3.10. U.K.

10.3.10.1. U.K. Market Revenue, By Type, 2025-2035

10.3.10.2. U.K. Market Revenue, By Component, 2025-2035

10.3.10.3. U.K Market Revenue, By Technology, 2025-2035

10.3.10.4. U.K Market Revenue, By Insulin Delivery Method, 2025-2035

10.3.10.5. U.K Market Revenue, By Distribution Channel, 2025-2035

10.3.10.6. U.K. Market Revenue, By End-user, 2025-2035

10.3.11. Italy

10.3.11.1. Italy Market Revenue, By Type, 2025-2035

10.3.11.2. Italy Market Revenue, By Component, 2025-2035

10.3.11.3. Italy Market Revenue, By Technology, 2025-2035

10.3.11.4. Italy Market Revenue, By Insulin Delivery Method, 2025-2035

10.3.11.5. Italy Market Revenue, By Distribution Channel, 2025-2035

10.3.11.6. Italy Market Revenue, By End-user, 2025-2035

10.3.12. Spain

10.3.12.1. Spain Market Revenue, By Type, 2025-2035

10.3.12.2. Spain Market Revenue, By Component, 2025-2035

10.3.12.3. Spain Market Revenue, By Technology, 2025-2035

10.3.12.4. Spain Market Revenue, By Insulin Delivery Method, 2025-2035

10.3.12.5. Spain Market Revenue, By Distribution Channel, 2025-2035

10.3.12.6. Spain Market Revenue, By End-user, 2025-2035

10.3.13. Rest of Europe

10.3.13.1. Rest of Europe Market Revenue, By Type, 2025-2035

10.3.13.2. Rest of Europe Market Revenue, By Component, 2025-2035

10.3.13.3. Rest of Europe Market Revenue, By Technology, 2025-2035

10.3.13.4. Rest of Europe Market Revenue, By Insulin Delivery Method, 2025-2035

10.3.13.5. Rest of Europe Market Revenue, By Distribution Channel, 2025-2035

10.3.13.6. Rest of Europe Market Revenue, By End-user, 2025-2035

10.4. Asia Pacific

10.4.1. Asia Pacific Market Revenue, By Country, 2025-2035(USD Million)

10.4.2. Asia Pacific Market Revenue, By Type, 2025-2035

10.4.3. Asia Pacific Market Revenue, By Component, 2025-2035

10.4.4. Asia Pacific Market Revenue, By Technology, 2025-2035

10.4.5. Asia Pacific Market Revenue, By Insulin Delivery Method, 2025-2035

10.4.6. Asia Pacific Market Revenue, By Distribution Channel, 2025-2035

10.4.7. Asia Pacific Market Revenue, By End-user, 2025-2035

10.4.8. China

10.4.8.1. China Market Revenue, By Type, 2025-2035

10.4.8.2. China Market Revenue, By Component, 2025-2035

10.4.8.3. China Market Revenue, By Technology, 2025-2035

10.4.8.4. China Market Revenue, By Insulin Delivery Method, 2025-2035

10.4.8.5. China Market Revenue, By Distribution Channel, 2025-2035

10.4.8.6. China Market Revenue, By End-user, 2025-2035

10.4.9. Japan

10.4.9.1. Japan Market Revenue, By Type, 2025-2035

10.4.9.2. Japan Market Revenue, By Component, 2025-2035

10.4.9.3. Japan Market Revenue, By Technology, 2025-2035

10.4.9.4. Japan Market Revenue, By Insulin Delivery Method, 2025-2035

10.4.9.5. Japan Market Revenue, By Distribution Channel, 2025-2035

10.4.9.6. Japan Market Revenue, By End-user, 2025-2035

10.4.10. India

10.4.10.1. India Market Revenue, By Type, 2025-2035

10.4.10.2. India Market Revenue, By Component, 2025-2035

10.4.10.3. India Market Revenue, By Technology, 2025-2035

10.4.10.4. India Market Revenue, By Insulin Delivery Method, 2025-2035

10.4.10.5. India Market Revenue, By Distribution Channel, 2025-2035

10.4.10.6. India Market Revenue, By End-user, 2025-2035

10.4.11. Australia

10.4.11.1. Australia Market Revenue, By Type, 2025-2035

10.4.11.2. Australia Market Revenue, By Component, 2025-2035

10.4.11.3. Australia Market Revenue, By Technology, 2025-2035

10.4.11.4. Australia Market Revenue, By Insulin Delivery Method, 2025-2035

10.4.11.5. Australia Market Revenue, By Distribution Channel, 2025-2035

10.4.11.6. Australia Market Revenue, By End-user, 2025-2035

10.4.12. South Korea

10.4.12.1. South Korea Market Revenue, By Type, 2025-2035

10.4.12.2. South Korea Market Revenue, By Component, 2025-2035

10.4.12.3. South Korea Market Revenue, By Technology, 2025-2035

10.4.12.4. South Korea Market Revenue, By Insulin Delivery Method, 2025-2035

10.4.12.5. South Korea Market Revenue, By Distribution Channel, 2025-2035

10.4.12.6. South Korea Market Revenue, By End-user, 2025-2035

10.4.13. Singapore

10.4.13.1. Singapore Market Revenue, By Type, 2025-2035

10.4.13.2. Singapore Market Revenue, By Component, 2025-2035

10.4.13.3. Singapore Canada Market Revenue, By Technology, 2025-2035

10.4.13.4. Singapore Market Revenue, By Insulin Delivery Method, 2025-2035

10.4.13.5. Singapore Market Revenue, By Distribution Channel, 2025-2035

10.4.13.6. Singapore Market Revenue, By End-user, 2025-2035

10.4.14. Rest of Asia Pacific

10.4.14.1. Rest of Asia Pacific Market Revenue, By Type, 2025-2035

10.4.14.2. Rest of Asia Pacific Market Revenue, By Component, 2025-2035

10.4.14.3. Rest of Asia Pacific Market Revenue, By Technology, 2025-2035

10.4.14.4. Rest of Asia Pacific Market Revenue, By Insulin Delivery Method, 2025-2035

10.4.14.5. Rest of Asia Pacific Market Revenue, By Distribution Channel, 2025-2035

10.4.14.6. Rest of Asia Pacific Market Revenue, By End-user, 2025-2035

10.5. Latin America

10.5.1. Latin America Market Revenue, By Country, 2025-2035(USD Million)

10.5.2. Latin America Market Revenue, By Type, 2025-2035

10.5.3. Latin America Market Revenue, By Component, 2025-2035

10.5.4. Latin America Market Revenue, By Technology, 2025-2035

10.5.5. Latin America Market Revenue, By Insulin Delivery Method, 2025-2035

10.5.6. Latin America Market Revenue, By Distribution Channel, 2025-2035

10.5.7. Latin America Market Revenue, By End-user, 2025-2035

10.5.8. Brazil

10.5.8.1. Brazil Market Revenue, By Type, 2025-2035

10.5.8.2. Brazil Market Revenue, By Component, 2025-2035

10.5.8.3. Brazil Market Revenue, By Technology, 2025-2035

10.5.8.4. Brazil Market Revenue, By Insulin Delivery Method, 2025-2035

10.5.8.5. Brazil Market Revenue, By Distribution Channel, 2025-2035

10.5.8.6. Brazil Market Revenue, By End-user, 2025-2035

10.5.9. Argentina

10.5.9.1. Argentina Market Revenue, By Type, 2025-2035

10.5.9.2. Argentina Market Revenue, By Component, 2025-2035

10.5.9.3. Argentina Market Revenue, By Technology, 2025-2035

10.5.9.4. Argentina Market Revenue, By Insulin Delivery Method, 2025-2035

10.5.9.5. Argentina Market Revenue, By Distribution Channel, 2025-2035

10.5.9.6. Argentina Market Revenue, By End-user, 2025-2035

10.5.10. Mexico

10.5.10.1. Mexico Market Revenue, By Type, 2025-2035

10.5.10.2. Mexico Market Revenue, By Component, 2025-2035

10.5.10.3. Mexico Market Revenue, By Technology, 2025-2035

10.5.10.4. Mexico Market Revenue, By Insulin Delivery Method, 2025-2035

10.5.10.5. Mexico Market Revenue, By Distribution Channel, 2025-2035

10.5.10.6. Mexico Market Revenue, By End-user, 2025-2035

10.5.11. Rest of Latin America

10.5.11.1. Rest of Latin America Market Revenue, By Type, 2025-2035

10.5.11.2. Rest of Latin America Market Revenue, By Component, 2025-2035

10.5.11.3. Rest of Latin America Market Revenue, By Technology, 2025-2035

10.5.11.4. Rest of Latin America Market Revenue, By Insulin Delivery Method, 2025-2035

10.5.11.5. Rest of Latin America Market Revenue, By Distribution Channel, 2025-2035

10.5.11.6. Rest of Latin America Market Revenue, By End-user, 2025-2035

10.6. MEA

10.6.1. MEA Market Revenue, By Country, 2025-2035(USD Million)

10.6.2. MEA Market Revenue, By Type, 2025-2035

10.6.3. MEA Market Revenue, By Component, 2025-2035

10.6.4. MEA Market Revenue, By Technology, 2025-2035

10.6.5. MEA Market Revenue, By Insulin Delivery Method, 2025-2035

10.6.6. MEA Market Revenue, By Distribution Channel, 2025-2035

10.6.7. MEA Market Revenue, By End-user, 2025-2035

10.6.8. GCC Countries

10.6.8.1. GCC Countries Market Revenue, By Type, 2025-2035

10.6.8.2. GCC Countries Market Revenue, By Component, 2025-2035

10.6.8.3. GCC Countries Market Revenue, By Technology, 2025-2035

10.6.8.4. GCC Countries Market Revenue, By Insulin Delivery Method, 2025-2035

10.6.8.5. GCC Countries Market Revenue, By Distribution Channel, 2025-2035

10.6.8.6. GCC Countries Market Revenue, By End-user, 2025-2035

10.6.9. South Africa

10.6.9.1. South Africa Market Revenue, By Type, 2025-2035

10.6.9.2. South Africa Market Revenue, By Component, 2025-2035

10.6.9.3. South Africa Market Revenue, By Technology, 2025-2035

10.6.9.4. South Africa Market Revenue, By Insulin Delivery Method, 2025-2035

10.6.9.5. South Africa Market Revenue, By Distribution Channel, 2025-2035

10.6.9.6. South Africa Market Revenue, By End-user, 2025-2035

10.6.10. Rest of Middle-East & Africa

10.6.10.1. Rest of Middle-East & Africa Market Revenue, By Type, 2025-2035

10.6.10.2. Rest of Middle-East & Africa Market Revenue, By Component, 2025-2035

10.6.10.3. Rest of Middle-East & Africa Market Revenue, By Technology, 2025-2035

10.6.10.4. Rest of Middle-East & Africa Market Revenue, By Insulin Delivery Method, 2025-2035

10.6.10.5. Rest of Middle-East & Africa Market Revenue, By Distribution Channel, 2025-2035

10.6.10.6. Rest of Middle-East & Africa Market Revenue, By End-user, 2025-2035

11. Company Profile

11.1. Medtronic plc

11.1.1. Business Overview

11.1.2. Financial Performance

11.1.3. Product/Service Offerings

11.1.4. Strategies & recent developments

11.1.5. SWOT Analysis

11.2. Bigfoot Biomedical

11.2.1. Business Overview

11.2.2. Financial Performance

11.2.3. Product/Service Offerings

11.2.4. Strategies & recent developments

11.2.5. SWOT Analysis

11.3. Johnson & Johnson

11.3.1. Business Overview

11.3.2. Financial Performance

11.3.3. Product/Service Offerings

11.3.4. Strategies & recent developments

11.3.5. SWOT Analysis

11.4. Tandem Diabetes Care, Inc.

11.4.1. Business Overview

11.4.2. Financial Performance

11.4.3. Product/Service Offerings

11.4.4. Strategies & recent developments

11.4.5. SWOT Analysis

11.5. Beta Bionics, Inc.

11.5.1. Business Overview

11.5.2. Financial Performance

11.5.3. Product/Service Offerings

11.5.4. Strategies & recent developments

11.5.5. SWOT Analysis

11.6. Insulet Corporation

11.6.1. Business Overview

11.6.2. Financial Performance

11.6.3. Product/Service Offerings

11.6.4. Strategies & recent developments

11.6.5. SWOT Analysis

11.7. Dexcom, Inc.

11.7.1. Business Overview

11.7.2. Financial Performance

11.7.3. Product/Service Offerings

11.7.4. Strategies & recent developments

11.7.5. SWOT Analysis

11.8. Defymed

11.8.1. Business Overview

11.8.2. Financial Performance

11.8.3. Product/Service Offerings

11.8.4. Strategies & recent developments

11.8.5. SWOT Analysis

11.9. Admetsys Corporation

11.9.1. Business Overview

11.9.2. Financial Performance

11.9.3. Product/Service Offerings

11.9.4. Strategies & recent developments

11.9.5. SWOT Analysis

11.10. Inreda Diabetic B.V.

11.10.1. Business Overview

11.10.2. Financial Performance

11.10.3. Product/Service Offerings

11.10.4. Strategies & recent developments

11.10.5. SWOT Analysis

11.11. TypeZero Technologies, LLC

11.11.1. Business Overview

11.11.2. Financial Performance

11.11.3. Product/Service Offerings

11.11.4. Strategies & recent developments

11.11.5. SWOT Analysis

11.12. Diabeloop

11.12.1. Business Overview

11.12.2. Financial Performance

11.12.3. Product/Service Offerings

11.12.4. Strategies & recent developments

11.12.5. SWOT Analysis

11.13. Roche Diabetes Care

11.13.1. Business Overview

11.13.2. Financial Performance

11.13.3. Product/Service Offerings

11.13.4. Strategies & recent developments

11.13.5. SWOT Analysis

11.14. Ypsomed

11.14.1. Business Overview

11.14.2. Financial Performance

11.14.3. Product/Service Offerings

11.14.4. Strategies & recent developments

11.14.5. SWOT Analysis

11.15. CamDiab

11.15.1. Business Overview

11.15.2. Financial Performance

11.15.3. Product/Service Offerings

11.15.4. Strategies & recent developments

11.15.5. SWOT Analysis

11.16. Zyoxel

11.16.1. Business Overview

11.16.2. Financial Performance

11.16.3. Product/Service Offerings

11.16.4. Strategies & recent developments

11.16.5. SWOT Analysis